NCT05886712View on ClinicalTrials.gov

Improving Access to Naloxone to Prevent Opioid Overdose Deaths (SAIA-Naloxone)

NAActive, not recruitingINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions

OverdoseImplementation as Usual

Interventions

OTHER

Naloxone

Naloxone

OTHER

Usual intervention

usual administered drug for overdose

Trial Locations (1)

94704

RTI International, Berkeley

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

University of California, San Diego

OTHER

collaborator

Heluna Health

OTHER

lead

RTI International

OTHER